(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
The most effective method to Recuperate After a Dental Embed Strategy: A Far reaching Guide - 2Sydney Sweeney is returning in 'The Housemaid's Secret': What to know about 'The Housemaid' sequel
- 3New peace laureate: Iran's arrest of Mohammadi 'confession of fear'
- 4Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- 5Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- Vote In favor of Your Favored Kind Of Attire
- Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- 4 Famous Attractions at Disneyland
- 80 km. on foot: Sharren Haskel’s three-day march in protest of haredi draft bill
- Instructions to Arrange Your Compensation During Medical caretaker Prospective employee meetings
- New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz
- Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
- Vote In favor of Your Favored Treat
